Antlia Bioscience, Inc. — Form D
Antlia Bioscience, Inc. of ENCINITAS, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-04-26. The offering totals $2.5M, of which $680K was reported sold. Industry: Other Technology.
Offering
- Filed: 2022-04-26
- Form: D
- Accession: 0001829522-22-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $2.5M
- Amount sold: $680K
- Remaining: $1.8M
- Investors: 10
- Date of first sale: 2022-04-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-443291
Issuer
- Name: Antlia Bioscience, Inc.
- CIK: 0001829522
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 1281 HYMETTUS AVE, ENCINITAS, CA, 92024
- Phone: 619-990-0290
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Brian Laurence Johnson | Director | Encinitas, CA |
| Brian Laurence Johnson | Executive Officer | Encinitas, CA |
| Nihal Sinha | Related Person | Encinitas, CA |
| Ben Auspitz | Related Person | Cambridge, MA |
| Ankit Mahadevia | Related Person | Cambridge, MA |
| Brian Laurence Johnson | Related Person | Encinitas, CA |
| Martin Taylor | Related Person | Encinitas, CA |
| Carlos Garcia Echeverria | Related Person | Encinitas, CA |
Other filings by this issuer (2)
More